Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
CJC-1295 + Ipamorelin is a USA-manufactured dual-peptide GH axis research blend combining CJC-1295 No DAC (ModGRF 1-29) a synthetic GHRH analogue that activates the GHRH receptor on anterior pituitary somatotrophs via Gs-cAMP signaling and Ipamorelin, a selective GH secretagogue that activates the ghrelin receptor (GHS-R1a) via the distinct Gq/11 intracellular pathway, providing simultaneous dual-receptor GH axis stimulation in a single research preparation
Bacteriostatic water is more universally compatible
Semaglutide and tirzepatide primarily target GLP-1 receptors, with tirzepatide adding GIP receptor activation
Weeks 2-4: Appetite approaches pre-treatment levels for most people
52 7mg 14mg 0.75mg
:max_bytes(150000):strip_icc()/Victozavs.Ozempic-SimilaritiesDifferences-f301d5db91914933990f700c243d7e62.jpg)
